Back
Werner Enterprises Vs. Biomarin Pharmaceutical Industry Stock Comparison
Sell
40
WERN
Werner Enterprises
Last Price:
37.53
Seasonality Move:
2.45%
Sell
33
BMRN
Biomarin Pharmaceutical
Last Price:
71.13
Seasonality Move:
5.7%
Sell
40
Werner Enterprises (WERN)
is a Sell
Is Werner Enterprises a Buy, Sell or Hold?
- The current Werner Enterprises [WERN] share price is $37.44. The Score for WERN is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- WERN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Biomarin Pharmaceutical (BMRN)
is a Sell
Is Biomarin Pharmaceutical a Buy, Sell or Hold?
- The current Biomarin Pharmaceutical [BMRN] share price is $70.55. The Score for BMRN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
WERN Stock Price Chart
What is Werner Enterprises's stock price today?
-
The Werner Enterprises share price today is $37.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and WERN is experiencing slight selling pressure.
BMRN Stock Price Chart
What is Biomarin Pharmaceutical's stock price today?
-
The Biomarin Pharmaceutical share price today is $70.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.
WERN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 55.02 | Buy |
| Chaikin Money Flow: | -229732 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.45 - 37.45) | Buy |
| Bollinger Bands (100): | (35.64 - 37.76) | Buy |
BMRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.98 | Sell |
| Relative Strength Index (14 RSI): | 20.79 | Sell |
| Chaikin Money Flow: | 1035913 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
WERN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.64 | Buy |
| 20-day SMA: | 36.92 | Buy |
| 50-day SMA: | 37.07 | Buy |
| 200-day SMA: | 38.18 | Sell |
| 8-day EMA: | 36.94 | Buy |
| 20-day EMA: | 36.9 | Buy |
| 50-day EMA: | 36.93 | Buy |
| 200-day EMA: | 37.97 | Sell |
BMRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.97 | Sell |
| 20-day SMA: | 86.7 | Sell |
| 50-day SMA: | 86.17 | Sell |
| 200-day SMA: | 87.12 | Sell |
| 8-day EMA: | 79.59 | Sell |
| 20-day EMA: | 84.09 | Sell |
| 50-day EMA: | 85.42 | Sell |
| 200-day EMA: | 86.31 | Sell |
Werner Enterprises Earnings Growth & WERN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.23 per share, a decrease this year of $1.08 per share, and an increase next year of $0.86 per share.
Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.
Werner Enterprises Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Biomarin Pharmaceutical Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||